3D conformation and crystal interaction insights into drug development challenges for HCV drug analogues via molecular simulations
Abstract ABT-333 and ABT-072 are two potent non-nucleoside NS5B polymerase inhibitors designed for the treatment of the hepatitis C virus (HCV). These structural analogs differ only by a minor substituent change, which disrupts the planarity of the naphthyl group on the ABT-333 compound through the...
Saved in:
| Main Authors: | Richard S. Hong, Alessandra Mattei, Mark E. Tuckerman, Ahmad Y. Sheikh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Communications Chemistry |
| Online Access: | https://doi.org/10.1038/s42004-025-01618-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug delivery process simulation-Quantifying the conformation dynamics of paclitaxel and cremophor EL.
by: Mafiz Uddin, et al.
Published: (2025-01-01) -
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes
by: Michał Brzdęk, et al.
Published: (2025-07-01) -
Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia
by: Afiono Agung Prasetyo, et al.
Published: (2013-06-01) -
Ab Initio and DFT Studies of Conformational Properties of Heteroatom Containing Ketene Analogues and Their Comparison with the Related Cyclic Analogues
by: S. Zahra Sayyed-Alangi, et al.
Published: (2012-01-01) -
Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan
by: Daisuke Nakamoto, et al.
Published: (2025-04-01)